A major medical journal has published a review of myeloproliferative neoplasms — a group of rare blood cancers — outlining what drives them, how inflammation plays a role, and which new targeted treatments may offer longer-lasting results.
The New England Journal of Medicine (NEJM) posted details of the review on its official account, drawing attention to what researchers describe as a clearer picture of how these conditions develop and how they might be better controlled. Myeloproliferative neoplasms (MPNs) are disorders in which the bone marrow produces too many blood cells — red cells, white cells or platelets — and can lead to serious complications if untreated.
The review focuses on three areas: the genetic faults (driver mutations) that trigger the conditions, the role of long-term inflammation in making them worse, and a new wave of targeted drug treatments that researchers say may achieve what is called durable disease modification — meaning the disease is not just managed short-term but potentially altered in a more lasting way.
MPNs are not common cancers, but they’re not vanishingly rare either. They include conditions such as polycythaemia vera, essential thrombocythaemia and myelofibrosis. Diagnosis often comes after routine blood tests flag unusual cell counts, sometimes before a patient has noticed anything wrong.
The NEJM is one of the world’s most widely cited peer-reviewed medical journals. Its review articles draw together existing research rather than presenting new trial data — so this piece reflects the current state of knowledge rather than a single new finding.
If you’re concerned about symptoms such as unexplained fatigue, night sweats, itching after a bath, or a feeling of fullness under your left ribs, speak to your GP. These can have many causes, but they’re worth raising. NHS 111 is also available around the clock for guidance on whether symptoms need urgent attention.
Key information
- GP referral: Anyone with persistent unexplained fatigue, unusual bruising or abnormal blood test results should ask their GP about further investigation
- NHS 111: Call 111 any time for non-emergency health advice
- Emergencies: Call 999 if symptoms are severe or sudden
Source: @NEJM
Blood Cancer Research: New Review Covers Causes and Treatments of Rare Bone Marrow Disorders Quiz
5 questions